Clinical Trial Details
— Status: Not yet recruiting
Administrative data
| NCT number |
NCT03214770 |
| Other study ID # |
oper 246 |
| Secondary ID |
|
| Status |
Not yet recruiting |
| Phase |
Phase 1
|
| First received |
|
| Last updated |
|
| Start date |
August 10, 2018 |
| Est. completion date |
September 1, 2019 |
Study information
| Verified date |
July 2018 |
| Source |
Cairo University |
| Contact |
Hanaa M Morsy, master |
| Phone |
01125930006 |
| Email |
hanaastamos[@]gmail.com |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
This is a randomized clinical study. 48 subjects with a confirmed diagnosis of deep carious
molars without pulpal lesions were randomized to one of two treatments: Patients treated with
Light-cured calcium silicate (Theracal) liner, or treated with light-cured calcium Hydroxide
(Biner LC) liner. Both two Treatments are with the step-wise excavation Technique.
Treatment will be done at baseline, collecting dentin sample before application of liner
material, then patients will be dismissed with Resin-modified Glass Ionomer restoration and
recalled after 6 months. Re-entry of tooth required for completing the step-wise excavation
technique collecting the second dentin sample after this time interval (6 months) and
permanently restore tooth with composite restoration. Dentin samples will be
microbiologically analyzed and the results will be statistically calculated.
Description:
1. Study setting:
This study will be carried out on adult patients attending to the operative clinic in
The Faculty of Oral and Dental Medicine, Cairo University, Egypt. The procedures will be
carried out by postgraduate student Hanaa Mohamed Morsy [B.D.S. 2011 from Misr
University for Science and Technology] without an assistant.
2. Variables of the study: A total of 48 carious lesions will be included in the study.
Divided into two groups 24 each. Thus 48 dentin samples will be collected from each
group (24 pre-operative dentin sample and 24 dentin sample after 6 months
post-operative)
3. Trial Description:
• Grouping of participants: Patients will be diagnosed to find carious molars reaching
dentin level. Participants will be divided to two groups randomly according to the type
of liner that will be placed and sample of dentin that will be taken before placement of
liner and after placement (6 months); D1 Dentin sample before and after treatment with
light-cured Calcium Silicate (Theracal) {n=48}, and D2 Dentin sample before and after
treatment with light-cured Calcium Hydroxide ( Biner LC){n=48}.
• Intervention/ Control: The procedure will be formed by removing the caries tissue till
reaching dentin, leaving the deep layer for the application of the step-wise technique.
Dentin sample will be taken by a spoon excavator for both groups and stored in a media
to be transferred to the microbiological lab for analysis at the time baseline of the
study (T1). Liner will be applied in the cavity for Group D1 using Theracal, and D2
using Biner LC. For both two groups, molars will be restored with Glass Ionomer
restoration at the time baseline. Patients will be recalled after 6 months for the
re-entry of the restored teeth , removing the Glass Ionomer restoration and collect the
dentin sample (T2) for evaluation of the microbiological count. Finally restoring the
teeth with Composite as the final permanent restoration. the procedure will follow the
manufacturer's instructions for every material used.
• Outcome: The outcome will be the bacterial count of Streptococcus Mutans of the dentin
samples collected from the tooth included in the study. Agar Diffusion test and Digital
Colony Counter will be conducted for the study. The measuring unit of the bacterial
count is CFU/ml. The first dentin sample will be collected in the baseline time and the
second dentin sample after 6 month for each group.
• Randomization: Randomization will be done according to a check list done by a dentist
other than the researcher including the number of participants divided into 2 subgroups
denoting with letter A, B.
• Microbiological analysis: Samples will be vortexed for 15 s, diluted, and measured
aliquots of the dilutions will be cultivated in duplicate in 3 different culture media.
Mitis Salivarius agar supplemented with sucrose and bacitracin will be used for counting
of mutans streptococci . For isolation of lactobacilli, Rogosa selective Lactobacillus
agar will be used. Counts of total colony forming units (CFU) will be obtained by
culture in brain heart infusion agar supplemented with 5% sheep blood and enriched with
k-hemin vitamin. The Mitis Salivarius will be incubated under CO 2 conditions at 37 0C
for 48 h. Colonies of mutans streptococci will be counted based on their morphology and
confirmed with catalase test. Rogosa SL Agar and the BHI will be incubated anaerobically
at 37 8C for 72 h. The BHI will be also incubated aerobically at 37 8C for 48 h to
determine the total aerobic counts (AE).
• Sample size calculation: The aim of this study is to evaluate the antibacterial action
of TheraCal (light-cured Calcium Silicate base/liner), comparing this material with
Calcium Hydroxide paste. If the expected clinical differences in bacterial count by
digital colony counter, agar diffusion test is 1± 1. Using power 80% and 5% significance
level , we will need to study 17 in each group to be able to reject the null hypothesis
that the population means of the experimental and control groups are equal. This number
is to be increase to 24 in each group to compensate for possible losses during follow up
according to Petrou et al., 2014. The sample size was calculated by PS program.
• Recruitment: Announcement to residents of outpatient clinic in Conservative Dentistry-
Faculty of Oral and Dental Medicine- Cairo University Egypt, to screen adult patient
during diagnosis for their chief complain so patients with at least one carious teeth
with no pulpal symptoms will be enrolled in this study, if they meet the eligibility
criteria.
• Allocation:
1. Sequence generation :
-Randomization is done by computer software www.random.org.
-The sequence generates 2 codes (A and B). Sample size 24 in each group to
compensate for possible losses during follow up.
2. Allocation and concealment arrangement:
- A checklist will be designed by a dentist other than the researcher to identify
each material specimen
3. Implementation :
-Allocation sequence will be generated at the Center of Evidence Based Dentistry,
Faculty of Oral and Dental Medicine - Cairo University.
-Participant enrollment will be done by the principle investigator.
• Blinding: It will be a single-blinded study so that the participant will be
blinded, the researcher and the data analysis will be unblinded.
• Data collection methods: There will be a file for each participant includes
his/her( informed consent, the 2 time interval appointments, all data including
address, phone numbers) and all information that will be needed for follow up.
- Retention:
-In order to ensure that the participants will come back for the sequence
visits, the patient will be asked for the telephone number and address and
will be called before the visit.
-Explanation of the importance of the study is explained to patient and the
importance on keeping the appointments.
- Data management :
-Explain to the patient the importance of this study and that commitment to
the appointments is mandatory to get the best results from this study.
- All data is documented in the patient sheet.
- Statistical Methods:
Data will be analyzed using IBM SPSS advanced statistics (Statistical Package for
Social Sciences), version 21 (SPSS Inc., Chicago, IL). Numerical data will be
described as mean and standard deviation or median and range. Categorical data will
be described as numbers and percentages. Data will be explored for normality using
Kolmogrov-Smirnov test and Shapiro-Wilk test. Comparisons between two groups for
normally distributed numeric variables will be done using the Student's t-test
while for non normally distributed numeric variables will be done by Mann-Whitney
test. Comparisons between categorical variables will be performed using the chi
square test. A p-value less than or equal to 0.05 will be considered statistically
significant. All tests will be two tailed.( Petrou et al., 2013)
• Data Monitoring: This study will be monitored by the supervisors who will have
full access to the results and will take the final decision to terminate the trial.
• Harms: No reported adverse effect of the intervention was reported. In case of
any harm during the trial it will be reported, documented and treated.
• Auditing: Auditing of the study design will be done by the evidence based
committee- Faculty of Oral and Dental Medicine- Cairo University.
- Ethics and dissemination:
-Patient consent.
-Detailed check list including the exact procedure and intervention that will
be performed, the number of visits, the importance of this study to the
participants, as well as its importance to the population, and the possible
adverse effects accompanied with the use of the intervention.
- Research ethics approval:
-This protocol and the template of informed consent form will be reviewed by
the Ethics Committee of scientific research, Faculty of Oral and Dental
Medicine- Cairo University.
- Protocol amendments:
-Any modifications to the protocol which may have an impact on the conduction
of the study, potential benefit of the patient or may affect the patient
safety, including changes of study objectives, study design, sample size,
study procedure or significant administrative aspects will require a formal
amendment to the protocol. Such amendment will be agreed upon by the council
of Conservative dentistry Department.
- Consent and assent:
- Researcher will discuss the trial with the participant's. They will be
able to discuss his thoughts with the researcher after a full explanation
of the procedure in simple words. A verbal assent will be taken from the
participating patient while a written consent is signed by the patient.
- Confidentiality:
- All study related information will be stored securely. All participants''
information will be stored in a locked file cabinets in areas with
limited access. Process and administrative forms will be identified by a
coded ID [identifier number] only to maintain participants'
confidentiality. All records that contain names or other personal
identifiers will be stored separately from study records identified by
code number.
- Declaration of interest:
Non-financial • Access to data: All principle investigators will be given access to
the data sets. All data sets will be password protected.
• Ancillary and post-trial care: Full mouth treatment will be offered to all the
participants in addition to post-operative care and preventive measures after the
end of the trial.
- Dissemination policy:
1. Trial results:
-The study results and conclusions are planned to be discussed in the
Department of Conservative Dentistry, Faculty of Oral and Dental
Medicine, Cairo University through a power point presentation.
- This study is planned to be published
2. Authorship:
- All the authors meet the criteria for authorship which are defined
by the International Committee of Medical Journals Editors.
- Before submission, Trial version will be reviewed and approved by
the authors, Evidence-Based Dentistry Committee and Research Ethics
Committee at Faculty of Oral and Dental Medicine- Cairo University
and screened for plagiarism detector to ensure original work.
- Role of authors will be declared in details before submission.
- No professional writers will be used C) Reproducible research The
trial reports and full study report will be available.
